Sonoma Pharmaceuticals Inc

About

Sonoma Pharmaceuticals Inc is a global pharmaceutical manufacturing company headquartered in Boulder, Colorado, specializing in the development and production of stabilized hypochlorous acid technology for diverse healthcare applications. The company operates advanced manufacturing facilities in Guadalajara, Mexico, serving markets across 55 countries worldwide through direct sales and strategic distribution partnerships. As a leader in pharmaceutical manufacturing, Sonoma Pharmaceuticals focuses on developing innovative solutions for wound care, eye care, dermatological conditions, podiatry, animal health care, and non-toxic disinfectants. Their proprietary stabilized hypochlorous acid platform technology is protected by patents and supported by decades of clinical data demonstrating safety and efficacy across multiple therapeutic areas. The company provides comprehensive pharmaceutical manufacturing services including custom formulation development, overflow manufacturing capabilities, and specialized production processes that maintain product stability and effectiveness over extended periods. Their manufacturing operations feature rigorous quality control systems and international regulatory expertise, ensuring compliance with global pharmaceutical standards. Sonoma Pharmaceuticals has established strategic partnerships to expand their product portfolio, including collaborations for co-marketing expanded eye care product lines and distribution agreements with global healthcare distributors for wound care products in the United States. With European operations headquartered in Roermond, Netherlands, the company continues to expand its international presence while maintaining its commitment to delivering high-quality pharmaceutical manufacturing solutions and innovative healthcare products to healthcare professionals and patients worldwide.